The increased expression of CDKN2A suggests potential compensatory mechanisms for disrupted p53-mediated tumor suppression, while genes like DLGAP5 and ANLN highlight the role of mitotic instability in SKCM progression. The gene discussed is CDKN2A; the disease is neoplasm.